@misc{indiciaee5d45c5a9a03,
  title = {TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models},
  author = {Kortleve, D. and Hammerl, D. and van Brakel, M. and Wijers, R. and Roelofs, D. and Kroese, K. and Timmermans, M. and Liao, C.-Y. and Trapman-Jansen, A. and Foekens, R. and Michaux, J. and de Beijer, M. and Buschow, S. I. and Demmers, J. A. and Kok, M. and Danen, E. H. J. and Bassani-Sternberg, M. and Martens, J. W. and Abbott, R. J. M. and Debets, R.},
  year = {2024},
  doi = {10.1101/2024.01.10.574978},
  url = {https://www.biorxiv.org/content/10.1101/2024.01.10.574978v1},
  note = {Source identifier: 10.1101/2024.01.10.574978}
}